(Q40039742)

16 September 2017

Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer (English)

1 reference

16 September 2017

1 reference

8

1 reference

16 September 2017

D Al-azawi

1

1 reference

16 September 2017

M Mc Ilroy

2

1 reference

16 September 2017

G Kelly

3

1 reference

16 September 2017

A M Redmond

4

1 reference

16 September 2017

F T Bane

5

1 reference

16 September 2017

S Cocchiglia

6

1 reference

16 September 2017

A D K Hill

7

1 reference

16 September 2017

language of work or name

English

0 references

publication date

3 December 2007

1 reference

16 September 2017

1 reference

16 September 2017

27

1 reference

16 September 2017

21

1 reference

16 September 2017

3021-3031

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210964

16 September 2017

0 references

cites work

Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Growth factor-dependent regulation of survivin by c-myc in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

The Myc/Max/Mad network and the transcriptional control of cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

c-Myc overexpression and endocrine resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

The ETS-domain transcription factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Role of Ets transcription factors in mammary gland development and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

inferred from DOI database lookup

7 January 2021

based on heuristic

Cytolysis mediated by ionophores and pore-forming agents: role of intracellular calcium in apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210964

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210964

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference